Natureceuticals Sdn Bhd clinical trials
The registry lists 7 studies whose lead sponsor is Natureceuticals Sdn Bhd. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 25, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 7studies on the registry
- 3open to participants now
- 3phase 3 studies under way
- 1reach primary completion within a year
Get an email when these change. Save the Natureceuticals Sdn Bhd studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Coming up
1 of Natureceuticals Sdn Bhd’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- DDec
- JJan ’27’27
- FFeb
- 1MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
The study
Add it to your calendar (.ics) → With an account.
All 7 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 425
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Natureceuticals Sdn Bhd.
- Natureceuticals Sdn Bhd7 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 7 of 7.
- Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line ChemotherapyRecruitingNCT07669519Phase 3
- Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast CancerRecruitingNCT07669467Phase 3
- A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.RecruitingNCT07669454Phase 3
- A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer Undergoing ChemotherapyCompletedNCT07669506Phase 3
- Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.CompletedNCT04552600Phase 1/2
- Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer AstheniaCompletedNCT04546607Phase 2/3
- To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.Status unknownNCT04542447Phase 1